about
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patientsBacterial contamination of inanimate surfaces and equipment in the intensive care unitBloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteriaAn atypical case of taravana syndrome in a breath-hold underwater fishing champion: a case report.A perioperative uncontrollable bleeding in an elderly patient with acquired hemophilia A: a case reportBlood Component Therapy and Coagulopathy in Trauma: A Systematic Review of the Literature from the Trauma Update Group.Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients.Effect of High-Fidelity Simulation on Medical Students' Knowledge about Advanced Life Support: A Randomized StudyUse of Cepheid Xpert Carba-R® for Rapid Detection of Carbapenemase-Producing Bacteria in Abdominal Septic Patients Admitted to Intensive Care Unit.Use of a Real-Time Training Software (Laerdal QCPR®) Compared to Instructor-Based Feedback for High-Quality Chest Compressions Acquisition in Secondary School Students: A Randomized Trial.Respiratory support techniques to avoid desaturation in critically ill patients requiring endotracheal intubation: A systematic review and meta-analysis.Should Reinke edema be considered a contributing factor to post-extubation failure?Neutrophil CD64 as a marker of infection in patients admitted to the emergency department with acute respiratory failure.Noninvasive ventilation in critically ill patients.Epidemiology and Characteristics of Episodic Breathlessness in Advanced Cancer Patients: An Observational Study.Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings.Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study.Pain intensity as prognostic factor in cancer pain management.Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain.Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain.WHO Needs High FIO2?Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia.Dying with or Because of Invasive Fungal Infection? The Role of Immunity Exhaustion on Patient Outcome.Should we Administer Antifungal Drugs Before the Diagnosis of Invasive Fungal Infection in Non-Neutropenic Critically Ill Patients?Ten important articles on noninvasive ventilation in critically ill patients and insights for the future: A report of expert opinionsLessons from uncertainty on antifungal treatment in ICU.Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?What is the risk of acquiring bacteria from prior intensive care unit bed occupants?Is it time to consider visual feedback systems the gold standard for chest compression skill acquisition?No-touch methods of terminal cleaning in the intensive care unit: results from the first large randomized trial with patient-centred outcomes.Rapid detection of carbapenem resistance: targeting a zero level of inadequate empiric antibiotic exposure?Is it time to combine untargeted antifungal strategies to reach the goal of 'early' effective treatment?Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?From bedside to bench: the missing brick for patients with fungal sepsis.The paradox of the evidence about invasive fungal infection prevention.Should We Use Dexmedetomidine for Sedation in Parturients Undergoing Caesarean Section Under Spinal Anaesthesia?ICU-acquired infections: It is not only about the number of patients per room.Use of thromboelastography in severe sepsis: a case-control study.Procalcitonin as a predictive marker for PCR test and blood culture results in suspected invasive candidemia.Use of Cepheid Xpert Carba-R® for rapid detection of carbapenemase-producing bacteria in critically ill, abdominal surgical patients: first report of an observational study.
P50
Q24186457-C23FB410-0AC6-4DB7-BBF6-159D3F9E728DQ26773771-662C9951-8144-40E7-BFEB-A75655147882Q26795565-9A061F8D-B39E-4F32-BF65-95F20D64442DQ30663041-940A6C40-28F9-488F-A19F-D145F2221023Q34286340-C09DB896-60A3-42FD-AA01-2CAAACE91FFCQ34679034-1B9FDE34-2AC6-4328-B4A7-3F4AEE868C71Q35100021-59685A1C-9A0C-4469-B25B-D9989231DB8CQ35587709-AF05A24C-75AC-4AE9-9583-F383633D2DA7Q36095013-4B0833D5-FA3B-4C45-9F3A-ECB53F44D85FQ36240401-D2CA058F-6417-4185-ADF5-0969F299CD63Q36372257-ADEFBBDE-7006-4F5A-9662-F6B8E0528871Q36424732-633F0F54-FCE4-49BE-87F5-DCA228192711Q36581294-AB1D2C30-ACCB-415D-9741-E1B5510DB2CCQ38539435-5893D26F-693B-4A4C-B7B1-3C850E1F2EAAQ39182768-6CCFAE95-1DEB-4076-B888-3301257487FBQ39184276-7B36BCDD-9D85-4E87-9E93-154E5669211CQ39184413-AE6A6FC2-8A19-4FAE-BA44-B90906659B47Q39198781-F7F0208A-CABC-49E8-9ED7-10EAC30BF72CQ39199331-553459F6-584A-4A00-A828-9232EF5ADBDEQ39205556-C0BFE4DA-868E-4B61-9934-46FD40C08C3CQ40068501-E3C23A66-B7C9-4548-8729-9B3CAF4E2B72Q40361579-7C559F3A-C71D-48BA-A217-0FD7502D71BFQ40383367-0CBDC7E2-0224-4B40-9A8E-1263C304B5BDQ40383385-467A7141-CAE8-4D0A-8C9C-6FC78C5810FCQ41613212-BB5E18E5-424A-4D00-BD69-F4E54C7F8795Q42148479-01A33485-B085-4688-9302-DBA695694A14Q42177820-66B4F5C6-4B4C-42EA-9E2F-6E9503127B63Q42314766-185E9BEA-22A2-4262-B04F-F696EBEE964BQ42332356-552DD23C-7CF2-491F-B64B-4211E1C0E924Q42339357-4BE44FEE-0F13-451E-9A52-47F5BDBC161DQ42349138-85434839-42A9-44C4-9566-6600927AE282Q42358748-212593B4-2FFE-4B38-A602-69C056B71DEFQ42378051-71CD1A44-7C22-4085-804A-3C90190228F6Q42587933-05E2227E-6A70-4646-98D2-13C49C4D984BQ42854908-761009DA-A885-4F27-8B6B-904798C564DBQ43109401-AEE16E73-EC99-42AB-848C-D6B746152BE0Q45201196-21CBE00E-5D15-4873-938A-26207B0B63BFQ45849320-38BBEFDD-7796-447C-844A-D377BF12DE8FQ45929934-E6265CFF-EBB9-42D0-84B2-41DF58AE9736Q46069513-715DCD40-B382-4DA6-9650-501FBF38672A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea Cortegiani
@ast
Andrea Cortegiani
@en
Andrea Cortegiani
@es
type
label
Andrea Cortegiani
@ast
Andrea Cortegiani
@en
Andrea Cortegiani
@es
prefLabel
Andrea Cortegiani
@ast
Andrea Cortegiani
@en
Andrea Cortegiani
@es
P1053
H-4902-2016
P106
P1153
56041745800
P31
P3829
P496
0000-0003-1416-9993
P569
2000-01-01T00:00:00Z